A common class of drugs called anticholinergics might boost risks for heart failure and other dangerous cardiac conditions, a new study says. People taking the largest amounts of anticholinergic drugs ...
The light-hearted debate, “Primary Cardiovascular Prevention with SGLT2 Inhibitors or GLP-1 Receptor Agonists: Are We Ready for Prime Time?” took place Monday during the 80th American Diabetes ...
Please provide your email address to receive an email when new articles are posted on . Most of the studies compared TNF inhibitors with non-TNF-inhibitor DMARDs. The results may indicate that ...
The Chosun Ilbo on MSN
GLP-1 obesity drugs may reduce addiction risks, study finds
A study has found that GLP-1 class obesity treatments, such as Wegovy and Mounjaro, may reduce the risk of alcohol or ...
Health Affairs' Senior Deputy Editor Rob Lott interviews Jihye Han of Brigham and Women's Hospital and Harvard University on her recent paper that takes a closer look at the regulatory treatments for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results